← Back to Search

Stepped collaborative care intervention for Pain (WBCCI Trial)

N/A
Waitlist Available
Led By Jennifer L. Steel, PhD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

WBCCI Trial Summary

This trial tests a web-based intervention to improve symptoms of depression, pain, and fatigue, and quality of life for advanced cancer patients, and to reduce stress and depression, and fewer cardiovascular risk factors in caregivers.

Eligible Conditions
  • Pain
  • Cancer
  • Fatigue
  • Depression

WBCCI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Quality of life (QoL)
Secondary outcome measures
Caregiver's Body Mass Index
Caregiver's blood pressure
Caregiver's metabolic syndrome
+14 more
Other outcome measures
Health care costs
Health care utilization

WBCCI Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Stepped collaborative care interventionExperimental Treatment1 Intervention
The 'Stepped Collaborative Care Intervention' includes at least biweekly contact from a care coordinator by phone and face to face visits occurring approximately every 2 months, and 24 hour 7 day a week access to a website that was specifically designed during the pilot study for advanced cancer patients from socioeconomically disadvantaged backgrounds.
Group II: Enhanced Usual CareActive Control1 Intervention
Patients randomized to the 'Enhanced Usual Care' arm receive their usual care from their medical team. However, if the patient scores in the clinical range on one or more of the three symptoms s/he will receive education about the symptom and be referred to the appropriate health care provider for further treatment in their community. The care coordinator will follow up with the patient after 3 weeks to assess barriers to treatment and assist further with accessing treatment if needed.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Stepped collaborative care intervention
2016
N/A
~460

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,719 Previous Clinical Trials
16,341,882 Total Patients Enrolled
16 Trials studying Pain
7,742 Patients Enrolled for Pain
Jennifer L. Steel, PhDPrincipal InvestigatorUPMC Departemnt of Surgery
1 Previous Clinical Trials
1 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this investigation include individuals of advanced age?

"Adherence to the trial's prerequisites suggests that participants must be 21 years old or above and not exceed 100 years of age."

Answered by AI

Are there specific eligibility criteria for participation in this experiment?

"This clinical trial aims to recruit 459 individuals aged between 21 and 100, who suffer from pain. In addition, participants must display no evidence of mental illness or suicidal thoughts; they should also be a spouse or cohabitating partner of an advanced cancer patient receiving care at UPMC's Liver cancer Center."

Answered by AI

Are there any available openings in this clinical trial for prospective participants?

"As displayed on clinicaltrials.gov, this research project has since concluded its patient recruitment drive which began on December 1st 2016 and ended in October 12th 2022. At present, there are 2103 other medical trials actively recruiting participants."

Answered by AI

What outcome is being sought in this experimental venture?

"This clinical trial, assessed at 6 and 12 month intervals, focuses on patient Quality of Life (QoL) as its primary outcome. Other metrics such as Caregiver's serum HDL/LDL concentration in milligrams per decilitre (mg/dl), alpha-fetoprotein level in nanograms per millilitre (ng/ml), and carcinoembryonic antigen amount in miligrams per litre (mg/L) are secondary objectives that will be evaluated through blood sample collection and processing."

Answered by AI
Recent research and studies
Contemporary Clinical TrialsJournal
The Next Generation of Collaborative Care: The Design of a Novel Web-based Stepped Collaborative Care Intervention Delivered via Telemedicine for People Diagnosed with Cancer
Steel, Jennifer L., Vincent Reyes, Dan P. Zandberg, Marci Nilsen, Lauren Terhorst, Geena Richards, Bhanu Pappu, et al.. 2021. “The Next Generation of Collaborative Care: The Design of a Novel Web-based Stepped Collaborative Care Intervention Delivered via Telemedicine for People Diagnosed with Cancer”. Contemporary Clinical Trials. Elsevier BV. doi:10.1016/j.cct.2021.106295.
Psycho-OncologyJournal
The Benefits and Consequences of the COVID‐19 Pandemic for Patients Diagnosed with Cancer and Their Family Caregivers
Steel, Jennifer L., Aarshati Amin, Tristen Peyser, Donna Olejniczak, Michael Antoni, Maureen Carney, Emily Tillman, et al.. 2022. “The Benefits and Consequences of the COVID‐19 Pandemic for Patients Diagnosed with Cancer and Their Family Caregivers”. Psycho-oncology. Wiley. doi:10.1002/pon.5891.
clinicaltrials.govStudy
Web-based Collaborative Care Intervention Study
Jennifer Steel 2016. "Web-based Collaborative Care Intervention Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02939755.
~55 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top